Your search returned 87 studies. (Get alerts for new studies):
- A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder
Conditions: Obsessive Compulsive Disorder
Location: Birmingham, Alabama
- Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent Restenosis
Conditions: Peripheral Arterial Disease
Location: Birmingham, Alabama
- Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients
Conditions: Acute Gouty Arthritis
Location: Anniston, Alabama
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Rome, Georgia
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Anniston, Alabama
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Birmingham, Alabama
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Cullman, Alabama
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Pell City, Alabama
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Pinson, Alabama
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Rome, Georgia
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Rome, Georgia
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
Location: Rome, Georgia
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
Location: Rome, Georgia
- Prospective Observational Epidemiologic Study of Maraviroc's Safety
Conditions: Human Immunodeficiency Virus
Location: Hobson City, Alabama
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
Location: Anniston, Alabama
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
Location: Anniston, Alabama
- S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Rome, Georgia
- S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Anniston, Alabama
- Eslicarbazepine Acetate Monotherapy Long Term Study
Conditions: Epilepsy
Location: Rome, Georgia
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Rome, Georgia
- S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Rome, Georgia
- S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Anniston, Alabama
- Longitudinal Surveillance Registry (LSR) of ACUITY Spiral
Conditions: Heart Failure
Location: Birmingham, Alabama
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Rome, Georgia
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: Anniston, Alabama
- S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer
Location: Anniston, Alabama
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Anniston, Alabama
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Rome, Georgia
- Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
Conditions: Thrombocytopaenia
Location: Rome, Georgia
- A Study in Second Line Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Rome, Georgia
- A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus - Connective Tissue Disease - Autoimmune Disease
Location: Anniston, Alabama
- Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL
Conditions: Cataract
Location: Rome, Georgia
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Anniston, Alabama
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Rome, Georgia
- SuperNOVA Clinical Stenting Trial
Conditions: Atherosclerosis of Native Arteries of the Extremities, Unspecified
Location: Memphis, Tennessee
- Study of the Contraceptive Efficacy and Safety of Amphora Gel Compared to Conceptrol Vaginal Gel
Conditions: Contraception
Location: Birmingham, Alabama
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Conditions: Advanced Prostate Cancer - Prostatic Neoplasms
Location: Birmingham, Alabama
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Conditions: Advanced Prostate Cancer - Prostatic Neoplasms
Location: Rome, Georgia
- Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
Conditions: Central Neuropathic Pain - Multiple Sclerosis
Location: Cullman, Alabama
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Birmingham, Alabama
- DeNovo NT Longitudinal Data Collection (LDC) Knee Study
Conditions: Degenerative Lesion of Articular Cartilage of Knee - Osteochondritis Dissecans
Location: Huntsville, Alabama
- A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
Conditions: Cardiovascular Disease, Rheumatoid Arthritis
Location: Rome, Georgia
- Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With Ccr5 Tropic
Conditions: HIV-1
Location: Hobson City, Alabama
- Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 1 Year of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis
Location: Anniston, Alabama
- A Global Phase 3 Safety Study of 120 Mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years
Conditions: Meningitis, Meningococcal
Location: Huntsville, Alabama
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Rome, Georgia
- Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Conditions: Cardiovascular Disease - Diabetes Mellitus, Type 2
Location: Pell City, Alabama
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Anniston, Alabama
- 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Conditions: Autosomal Dominant Polycystic Kidney Disease
Location: Huntsville, Alabama
- A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Conditions: Type 2 Diabetes
Location: Birmingham, Alabama
- A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
Conditions: Cutaneous Lupus Erythematosus
Location: Anniston, Alabama
- A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
Conditions: Cutaneous Lupus Erythematosus
Location: Oxford, Alabama
- Study Evaluating the Safety and Efficacy Of Carboplatin/Paclitaxel And Carboplatin/Paclitaxel/Bevacizumab With and Without GDC-0941 in Patients With P
Conditions: Non-Small Cell Lung Cancer
Location: Birmingham, Alabama
- Combining Lesinurad With Allopurinol in Inadequate Responders
Conditions: Gout
Location: Pinson, Alabama
- Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
Conditions: Myocardial Infarction - Acute Coronary Syndromes - Unstable Angina
Location: Rome, Georgia
- A Study to Evaluate the Efficacy and Safety of a Single Application of QUTENZA Compared to That of Placebo in Reducing Pain Intensity in Subjects With
Conditions: Diabetic Peripheral Neuropathy - Pain
Location: Anniston, Alabama
- Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
Conditions: Irritable Bowel Syndrome With Diarrhea
Location: Anniston, Alabama
- Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
Conditions: Irritable Bowel Syndrome With Diarrhea
Location: Birmingham, Alabama
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Huntsville, Alabama
- Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J
Conditions: Irritable Bowel Syndrome
Location: Pell City, Alabama
- Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment
Conditions: Type 2 Diabetes Mellitus - Renal Impairment
Location: Anniston, Alabama
- A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Conditions: Asthma
Location: Pell City, Alabama
- A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Conditions: Asthma
Location: Oxford, Alabama
- Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis
Conditions: Relapsing Remitting Multiple Sclerosis
Location: Cullman, Alabama
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus - Hepatitis B
Location: Huntsville, Alabama
- MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone
Conditions: Relapsing-remitting Multiple Sclerosis (RRMS)
Location: Cullman, Alabama
- Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis
Location: Anniston, Alabama
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
Location: Anniston, Alabama
- Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Conditions: Management of Anemia in Chronic Kidney Disease Patients Not on Dialysis.
Location: Anniston, Alabama
- Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Conditions: Management of Anemia in Chronic Kidney Disease Patients Not on Dialysis.
Location: Birmingham, Alabama
- An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
Conditions: Opioid Dependence
Location: Birmingham, Alabama
- A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB in Patients With COPD Who Have Moderate to Severe
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Location: Anniston, Alabama
- Efficacy and Safety Study With Diltiazem Hydrochloride Cream to Treat Anal Fissures
Conditions: Chronic Anal Fissures
Location: Anniston, Alabama
- Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P
Conditions: Rhinitis, Allergic, Perennial - Rhinitis, Allergic, Nonseasonal
Location: Birmingham, Alabama
- To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (
Conditions: Rheumatoid Arthritis
Location: Anniston, Alabama
- A Study to Evaluate Chronic Hepatitis C Infection
Conditions: Chronic Hepatitis C Infection
Location: Birmingham, Alabama
- A Study of LY2940680 in Small Cell Lung Cancer
Conditions: Small Cell Lung Carcinoma
Location: Rome, Georgia
- Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia
Conditions: Hyperkalemia
Location: Anniston, Alabama
- Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Conditions: Dyslipidemia
Location: Birmingham, Alabama
- Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
Conditions: Multiple Sclerosis
Location: Cullman, Alabama
- Safety and Efficacy Trial of Testosterone Undecanoate
Conditions: Male Hypogonadism
Location: Birmingham, Alabama
- Safety and Efficacy Trial of Testosterone Undecanoate
Conditions: Male Hypogonadism
Location: Birmingham, Alabama
- A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer
Conditions: Squamous Non Small Cell Lung Cancer
Location: Rome, Georgia
- Secukinumab Efficacy and Safety Study in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-TNFα Agents.
Conditions: Rheumatoid Arthritis
Location: Anniston, Alabama
- Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age
Conditions: Meningitis - Meningococcal Infection - Diphtheria - Tetanus - Pertussis - Haemophilus Influenzae Serotype b (Hib)
Location: Birmingham, Alabama
- Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age
Conditions: Meningitis - Meningococcal Infection - Diphtheria - Tetanus - Pertussis - Haemophilus Influenzae Serotype b (Hib)
Location: Pinson, Alabama
- Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076 AM1)
Conditions: Osteoporosis
Location: Birmingham, Alabama
|